Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

burke & herbert - BHRB

BHRB

Close Chg Chg %
62.18 -0.27 -0.43%

Closed Market

61.91

-0.27 (0.43%)

Volume: 122.75K

Last Updated:

May 19, 2026, 4:00 PM EDT

Trade Now

Company Overview: burke & herbert - BHRB

BHRB Key Data

Open

$62.00

 Day Range

61.65 - 62.54

52 Week Range

54.45 - 70.90

 Market Cap

$1.25B

Shares Outstanding

20.15M

 Public Float

16.13M

Beta

0.24

 Rev. Per Employee

N/A

P/E Ratio

8.06

 EPS

$7.76

Yield

353.81%

 Dividend

$0.55

EX-DIVIDEND DATE

May 15, 2026

 SHORT INTEREST

N/A

AVERAGE VOLUME

137.52K

  

BHRB Performance

1 Week
 
 0.72%
 
1 Month
 
 -6.55%
 
3 Months
 
 -8.88%
 
1 Year
 
 11.79%
 
5 Years
 
 18.49%
 

BHRB Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 73.25
Number of Ratings 4 Current Quarters Estimate 1.94
FY Report Date 06 / 2026 Current Year's Estimate 8.095
Last Quarter’s Earnings 1.79 Median PE on CY Estimate N/A
Year Ago Earnings 7.72 Next Fiscal Year Estimate 8.813
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 4 4 4 4
Mean Estimate 1.94 2.17 8.10 8.81
High Estimates 2.06 2.19 8.32 9.00
Low Estimate 1.79 2.15 7.97 8.50
Coefficient of Variance 5.76 0.88 1.91 2.55

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 3 2 1
OVERWEIGHT 0 0 0
HOLD 1 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Burke & Herbert - BHRB

Date Name Shares Transaction Value
Apr 29, 2026 Shawn P. McLaughlin Director 68,000 Open market or private purchase of non-derivative security Non-derivative transaction at $64.8 per share 4,406,400.00
Feb 20, 2026 Robert S. Tissue EVP, Financial Strategy 52,290 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 David P. Boyle Chair & CEO; Director 72,720 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Brad E. Ritchie EVP, Chief Lending Officer 23,737 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Shannon B. Rowan EVP, Wealth Services 5,060 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Lauren N. Kimlel EVP, Branch Banking 3,718 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Danyl R. Freeman Chief Human Resources Officer 4,053 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Joseph W. Hager Chief Operating Officer 7,493 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Angela Zirk EVP, Chief Experience Officer 3,012 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Jennifer Schmidt EVP, Chief Risk Officer 4,472 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Robert V. Hintelmann Chief Credit Officer 5,550 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2026 Patrick Huffman SVP, Chief Accounting Officer 1,495 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Sep 16, 2025 Gary L. Hinkle Director 248,559 Open market or private purchase of non-derivative security Non-derivative transaction at $61.5 per share 15,286,378.50
Sep 16, 2025 Gary L. Hinkle Director 250,159 Open market or private purchase of non-derivative security Non-derivative transaction at $61.7 per share 15,434,810.30
Jun 6, 2025 Jose D. Riojas Director 19,000 Open market or private purchase of non-derivative security Non-derivative transaction at $55.85 per share 1,061,150.00

Burke & Herbert in the News